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A 21-year-old patient with pulmonary atresia and ventricular septal defect (PA-
VSD) was admitted to the hospital for tubal ligation. Invasive arterial and cen-
tral venous (CVP) pressure, pulse oximetric oxygen saturation (SpO2), and
(from the tip of oximetric central venous catheter) central venous oxygen satu-
ration (ScvO2) and oxygen extraction rate (ExO2) were continuously moni-
tored. Heart rate (range: 68-75beat/min), mean arterial pressure (80-90 mmHg),
CVP (7-10 mmHg), SpO2 (79-90 percent), ScvO2 (57-70 percent), and ExO2
(21-30 percent) remained stable during epidural anesthesia and transvaginal
sterilization. Following an overnight stay (peak SpO2 92 percent; peak ScvO2
71 percent; trough ExO2 21 percent), the oxygen data returned to baseline on
awakening (SpO2 <80 percent, ScvO2 <55 percent, ExO2 >35 percent), and the
patient was discharged. In PA-VSD, a single-outlet double-ventricle anomaly,
CVP reflects the preload ofsystemic ventricle. As the mixed venous oxygen sat-
uration cannot be defined, ScvO2 is the best available indicator of the whole
body oxygen consumption. Continuous monitoring of CVP, ScvO2 and ExO2
in the superior vena cava may provide more insight into the response to anes-
thesia and surgery in patients with PA-VSD.
INTRODUCTION
Pulmonary atresia with ventricular septal defect (PA-VSD)d, previously classified as
a variant of truncus arteriosus, is currently recognized as an extreme form of the tetralo-
gy ofFallot. The pulmonary blood supply arises from the descending and, rarely, abdom-
inal aorta, subclavian, pleural or coronary arteries. Morphology of the pulmonary perfu-
sion varies widely, and the extreme form is characterized by atretic or hypoplastic non-
confluent pulmonary arteries and multiple, usually stenotic, aortopulmonary collaterals.
The right ventricular outlet ends blindly and the venous blood is pumped through a large,
usually infundibular VSD, directly into the overriding aorta [1-3]. An unrestricted right-
left intracardiac shunt and severe cyanosis characterize this single-outlet double-ventricle
anomaly. The pulmonary blood flow (natural or surgical palliative) may become abundant
and lead to pulmonary vascular disease and Eisenmenger syndrome [4-7]. Life expectan-
cy in PA-VSD is low, but rare patients survive up to the sixth decade. In previous years, a
majority of infants were treated by a palliative surgical shunt only, until recently a com-
plete surgical repair started to be recommended in selected cases [1-3, 8, 9]. Despite a low
prevalence and a moderate survival rate into the adulthood, patients with PA-VSD are
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occasionally presented for non-cardiac surgery [4-7, 10, 11]. The management ofa patient
undergoing tubal ligation is described, emphasizing the importance of central venous
pressure (CVP) and central venous oxygen saturation (ScvO2) monitoring in PA-VSD
during and following anesthesia and surgery.
CASE REPORT
A cyanotic 21-year-old patient was admitted to the hospital for tubal ligation. At the
age of one year, the heart catheterization revealed PA-VSD, hypoplastic pulmonary arter-
ies, an overriding aorta and a patent ductus arteriosus. Aortopulmonary surgical
(Waterstone-Cooley) shunt was done. Cyanosis and erythrocytosis progressed, and her
exercise tolerance decreased. A correction of the anomaly was considered impossible.
Another surgical shunt was attempted twice but failed to improve systemic oxygenation.
When the patient reached adult age, a possible pregnancy was considered to carry too
many maternal and fetal risks. On admission, the patient was found moderately dyspnoic
at rest, with marked central and peripheral cyanosis, clubbing of digits, a regular periph-
eral arterial pulse of 84 beats/min and a blood pressure of 130 to 80 mmHg. Her body
weight was 49 kg and height was 165 cm. Except for a hemoglobin of21.3 g/dL, a hema-
tocrit of 62 percent and a prothrombin time of 12.6 sec (INR 1.23; normal <11 sec), lab-
oratory analyses were within normal limits. Transthoracic echocardiography showed a
hypertrophic right ventricle, a large malaligned VSD, a normal right and left ventricular
function, a mild tricuspid and aortic valve insufficiency and a dilated ascending aorta
(Figure 1). Ductus and surgical shunt were not visible.
Figure 1. Transthoracic echocardio-
graphic view of the right and left ven-
tricle, malaligned ventricular septal
defect, closed (top) and open (bottom)
aortic valve and overriding aorta in a
21-year old patient with PA-VSD.
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In the operating theater, ECG electrodes and a pulse oximetric probe were attached.
Midazolam, 1 mg, was given intravenously. Radial artery (22 g), lumbar extradural (16 g;
at the level ofL 2-3) and, through the right internaljugular vein, oximetric central venous
catheters (Edslab, H-7.5F, Baxter, Irvine, CA) were placed under local anesthesia. Oxygen
(5-8 L/min) was given by face mask. Optical module ofthe oximetric catheter, which uses
double-wavelength fiberoptic reflection-spectrophotometry, and a pulse oximetric probe
were connected to the corresponding instrument (Explorer, Baxter, Irvine, CA). ScvO2
from the catheter tip in the superior vena cava, pulse oximetry (SpO2), oxygen extraction
rate (ExO2; provided through the SpO2-ScvO2 difference, neglecting the influence ofP02
values), heart rate and an indicator of the oximetric signal quality were continuously dis-
played as digital values, figure lines and bars on the screen. Co-oximetric arterial (SaO2)
and ScvO2 values (82 percent and 59 percent, respectively) were obtained from corre-
sponding blood samples, and using initial values of hemoglobin (21.3 g/dL) and hemat-
ocrit (62 percent), the oximetric system was calibrated. Amoxicillin 2.2 g was given.
Following a test dose (3 mL of lidocaine 2 percent [60 mg] with epinephrine [15 gg]),
epidural anesthesia was induced over a period of 60 min. Lidocaine 2 percent (total 260
mg) with epinephrine, bupivacaine 0.5 percent (total 50 mg) and a single dose offentanyl
(0.05 mg) were given. The block spread up to the T6 dermatome level. The patient was
placed into lithotomy position. Midazolam, 1 mg intravenously, was repeated. Heart rate
(68-75 beat/min), arterial pressure (systolic 112-135, diastolic 62-70, mean 80-92 mmHg)
and CVP (mean 7-10 mmHg) remained stable during the procedure. SpO2 and ScvO2
increased from 79 to 90 percent and from 57 to 70 percent, respectively, and ExO2
decreased from 30 percent to 21 percent (Figures 2 and 3). A total of 1600 mL ofRinger's
lactate and 500 mL 6 percent hydroxyethyl starch solution was infused. At the end ofoper-
ation, hemoglobin was 20.2 g/dL, hematocrit 61 percent, arterial pH 7.43, pO2 6.9 kPa
(kPa = 7.502 mmHg), pCO2 4.6 kPa and base deficit -0.1 mmol/L. Analgesia was contin-
ued by an epidural infusion of bupivacaine 0.125 percent 4-8 mL/h and one dose of fen-
tanyl 0.05 mg. Low-molecular-weight heparin was given subcutaneously, and midazolam
3.75 mg was given orally. Oxygen 4 L/min was provided by a nasal catheter. Following an
overnight stay (peak SpO2, 92 percent; peakScvO2, 71 percent; trough ExO2, 20 percent),
the oxygen data returned to baseline on awakening (SpO2 <80 percent, ScvO2 <55 per-
cent, ExO2 >35 percent; Figure 4). All catheters were removed, and the patient was dis-
charged on the following day.
DISCUSSION
Limited oxygen availability and reduced exercise tolerance are characteristics of
patients with cyanotic congenital heart disease [1-3, 12-14]. Laparoscopic sterilization
under local anesthesia and monitored sedation has been recommended for these patients
[15]. Initially a laparoscopic procedure was considered, but due to unpredictable response
to the increased intrabdominal pressure and possible uncontrolled gas distribution, a deci-
sion was made to perform the tubal ligation transvaginally. A slow induction and titrated
maintenance of epidural block were tolerated without difficulties [4, 6, 10, 16-19]. CVP
was considered crucial for the management ofthis patient, and the intravenous fluids were
given correspondently. A transseptal pressure equalization in PA-VSD offers the opportu-
nity to monitor the preload of the systemic (right and left) ventricle by extrapolating CVP
for the right atrial and ventricular end-diastolic pressure. The ventricular function is prone
to decompensation [1-3], and the heart rate response to exercise (and anesthesia?) could be
abnormally decreased in patients with PA-VSD [13]. Maintained CVP and heart rate were
considered as a prime guarantee of sufficient cardiac output and systemic and pulmonary
17Weiss et al.: Monitoring in PA-VSD
DD f' C T T
15:00 15:15 14:30 14:45
pOD
C0
Sco2
EOD
EX02
N
so
C:
Figure 2. Pulse oximetric saturation (SpO2) (top), central venous oxygen saturation (ScvO2)
(middle) and oxygen extraction rate (ExO2) recording during the instrumentation, start of
anesthesia and positioning.
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Figure 3. Intraoperative recording of oximetric parameters (as in Figure 2).
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Figure 4. Recording of oximetric parameters (as in Figure 2) during the night after the pro-
cedure.
blood flow. A mild sedation contributed to calm spontaneous breathing and, at lower oxy-
gen consumption, to high SpO2 and ScvO2 and low ExO2 during the procedure and nat-
ural sleep (Figures 2-4). It seems that a near-maximal pulmonary blood flow and oxy-
genation were provided for the extreme form of PA-VSD. Further pharmacologic options,
if required, are somewhat controversial [7, 10, 14, 16-18, 20, 21]. In PA-VSD and other
anomalies without dynamic subvalvular obstructions, the drugs with positive chronotrop-
ic and inotropic properties should be preferentially used, as pure vasoconstrictors may pro-
voke bradycardia, decrease the cardiac output and/or, directly acting on the aortopul-
monary collaterals, further reduce the fragile pulmonary blood flow.
Venous blood does not sufficiently mix in the right heart in PA-VSD, and the mixed
venous oxygen saturation could not be defined in the presence of an intracardiac shunt.
Systemic oxygen transport in cyanotic patients is predominantly dependent on blood flow
(cardiac output) and much less on oxygen content. When exposed to decreasing oxygen
delivery and with cardiac output near to or at the upper limit ofmaximal performance, the
ExO2 rate must rapidly increase. ExO2 varies inversely with venous oxygen content and,
in extreme situations, may exceed 50 percent [12]. In PA-VSD, ScvO2 from the superior
caval blood reflects the oxygen supply/demand not only from the upper part but from the
lower part of the body, as well. Sudden changes in the oxygen balance and an increased
ExO2 below diaphragm will decrease the oxygen content in the inferior vena cava. A high
inferior caval blood flow, representing roughly two-thirds of the cardiac output [22],
reaches the aorta through VSD and directly influences Sa02. Thus, an oxygen
supply/demand imbalance in the lower part of the body will lead to an instant decrease of
Sa02, followed by decreased ScvO2 and increased ExO2 in the superior vena cava. The
actual caval oxygen contents, ExO2 and systemic oxygen delivery will depend individu-
ally on the duration and severity of oxygen debt, blood flow redistribution to preserve the
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cerebral and myocardial blood flow, Hb concentration, regional oxygen consumption [22-
24], additional load ofpregnancy [4, 6, 11, 16, 25] and intercurrent therapeutic measures.
In conclusion, in addition to the monitoring of heart rate, ECG, arterial pressure and
Sa/SpO2, a continuous measurement ofCVP, ScvO2 and ExO2 in the superior vena cava
may provide more insight into the hemodynamic response to anesthesia and surgery in
patients with PA-VSD and similar congenital heart diseases.
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